Don't miss any news, subscribe to our press releases.
Board of Directors
Björn Sjöstrand
The President
Svein Mathisen
Member of the Board
Fredrik Lehmann
Member of the Board
Rune Nordlander
Member of the Board
Karen From
Member of the Board
Management team
Johan Emilsson
Chief Executive Officer
Mathias Skalmstad
Chief Financial Officer
Martin Andersson
Chief Scientific Officer
Anne-Marie Wenthzel
Chief Business Officer
Auditor
Öhrlings PricewaterhouseCoopers AB,
Mr Niclas Bergenmo
Öhrlings PricewaterhouseCoopers AB was elected as auditor at the last Annual General Meeting. Authorised public accountant Niclas Bergenmo was appointed auditor in charge.
Adopted at the Annual General Meeting on 8 May 2024.
SECTION 1 COMPANY NAME
The company's name is Sprint Bioscience AB (publ).
SECTION 2 SEAT OF THE BOARD
The Board of Directors has its seat in Stockholm.
3 § ACTIVITIES
The company shall engage in the development of pharmaceuticals and related activities.
SECTION 4 SHARE CAPITAL
The share capital shall be not less than SEK 6 000 000 and not more than SEK 24 000 000.
5 § NUMBER OF SHARES
The number of shares shall be not less than 60 000 000 and not more than 240 000 000.
SECTION 6 BOARD OF DIRECTORS AND AUDITORS
The Board of Directors consists of 3-10 members with a maximum of 10 deputies. It is elected annually at the Annual General Meeting for the period until the next Annual General Meeting is held.
1-2 auditors with or without deputy auditors are elected at the Annual General Meeting for the period until the Annual General Meeting is held in the fourth financial year after the election.
SECTION 7 NOTICE
Notice of a general meeting shall be published in Post- och Inrikes Tidningar and on the company's website. At the time of the notice, information that the notice has been issued shall be announced in Svenska Dagbladet.
Notice of an annual general meeting shall be given not earlier than six weeks and not later than four weeks before the meeting and, in the case of an extraordinary general meeting which is not to consider an amendment to the articles of association, not earlier than six weeks and not later than two weeks before the meeting.
SECTION 8 GENERAL MEETING
The general meeting shall be held in Stockholm or Huddinge. The AGM is held annually within 6 months of the end of the financial year.
The following matters shall be dealt with at the Annual General Meeting:
At a general meeting, each person entitled to vote may vote in favour of the whole number of shares represented by him without any limit on the number of votes.
SECTION 9 FINANCIAL YEAR
The financial year is 0101 - 1231.
SECTION 10 PARTICIPATION IN GENERAL MEETINGS
In order to attend a general meeting, shareholders must notify the company of their intention to attend and the number of their assistants no later than the date specified in the notice convening the meeting. This day may not be a Sunday, other public holiday, Saturday, Midsummer's Eve, Christmas Eve or New Year's Eve and may not fall earlier than the fifth weekday before the meeting. The number of assistants may not exceed two.
SECTION 11 RECONCILIATION CLAUSE
The company's shares shall be registered in a CSD register in accordance with the Financial Instruments Accounts Act (1998:1479).